SCANGOS GEORGE A 13D and 13G filings for Vir Biotechnology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 4:05 pm Sale |
2021-12-31 | 13G | Vir Biotechnology, Inc. VIR |
SCANGOS GEORGE A | 6,266,581 4.790% |
-734,727 (-10.49%) |
Filing |
| 2021-02-12 5:00 pm Purchase |
2020-12-31 | 13G | Vir Biotechnology, Inc. VIR |
SCANGOS GEORGE A | 7,001,308 5.500% |
52,329 (+0.75%) |
Filing |